Get the latest updates and insights delivered to your inbox
Aug 21, 2026
Merck and Moderna say experimental mRNA melanoma vaccine shows promising results
Merck and Moderna announced positive results earlier this week in a late-stage trial of a skin cancer treatment. KYW Newsradio’s Matt Coughlin spoke with local researchers about the experimental vaccine. (Photo Illustration by Nikolas Kokovlis/NurPhoto via Getty Images)